Please login to the form below

Not currently logged in
Email:
Password:

tezepelumab

This page shows the latest tezepelumab news and features for those working in and with pharma, biotech and healthcare.

AZ, Amgen’s investigational asthma drug comes good in phase 3

AZ, Amgen’s investigational asthma drug comes good in phase 3

OCS). Over 52 weeks, tezepelumab hit the primary endpoint of the trial after demonstrating a statistically significant and clinically meaningful reduction in AAER. ... In September 2018, tezepelumab scored a breakthrough therapy designation (BTD) from

Latest news

More from news
Approximately 2 fully matching, plus 7 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Spirit

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics